Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 31.60%-5.69M | ---- | 70.01%-8.31M | ---- | -578.01%-27.72M | ---- | -64.91%5.8M | ---- | 140.89%16.53M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 27.78%-117K | ---- | -752.63%-162K | ---- | -11.76%-19K | ---- | 0.00%-17K | ---- | 19.05%-17K |
| Impairment and provisions: | ---- | -299.68%-1.23M | ---- | 295.56%616K | ---- | -346.09%-315K | ---- | -95.00%128K | ---- | 266.24%2.56M |
| -Impairmen of inventory (reversal) | ---- | -221.15%-1.23M | ---- | -21.59%-383K | ---- | -346.09%-315K | ---- | -95.00%128K | ---- | 266.24%2.56M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | --999K | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 22.22%5.5M | ---- | -43.75%4.5M | ---- | 900.00%8M | ---- | -122.22%-1M | ---- | 245.16%4.5M |
| -Fair value of investment properties (increase) | ---- | 22.22%5.5M | ---- | -43.75%4.5M | ---- | 900.00%8M | ---- | -122.22%-1M | ---- | 245.16%4.5M |
| Asset sale loss (gain): | ---- | 2,425.00%186K | ---- | 91.30%-8K | ---- | -185.98%-92K | ---- | -94.35%107K | ---- | 47.24%1.9M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 2,425.00%186K | ---- | 91.30%-8K | ---- | -185.98%-92K | ---- | -94.35%107K | ---- | 47.24%1.9M |
| Depreciation and amortization: | ---- | 2.19%16.46M | ---- | -8.93%16.11M | ---- | -3.76%17.69M | ---- | -27.15%18.38M | ---- | 26.41%25.23M |
| -Amortization of intangible assets | ---- | 594.52%507K | ---- | 62.22%73K | ---- | -11.76%45K | ---- | -40.00%51K | ---- | 44.07%85K |
| -Other depreciation and amortization | ---- | -1.47%201K | ---- | -5.99%204K | ---- | -2.69%217K | ---- | 7.21%223K | ---- | -1.42%208K |
| Financial expense | ---- | -6.80%7.21M | ---- | 49.92%7.74M | ---- | 30.53%5.16M | ---- | 4.25%3.95M | ---- | -36.81%3.79M |
| Exchange Loss (gain) | ---- | -28.52%3.95M | ---- | 321.57%5.53M | ---- | -15,487.50%-2.49M | ---- | 57.89%-16K | ---- | -111.66%-38K |
| Special items | ---- | ---- | ---- | ---12K | ---- | ---- | ---- | -110.80%-46K | ---- | 166.25%426K |
| Operating profit before the change of operating capital | ---- | 1.08%26.27M | ---- | 12,276.67%25.99M | ---- | -99.23%210K | ---- | -50.28%27.28M | ---- | 70.57%54.87M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 256.68%2.59M | ---- | -107.98%-1.65M | ---- | 7,775.29%20.71M | ---- | 102.44%263K | ---- | -166.52%-10.77M |
| Accounts receivable (increase)decrease | ---- | -179.31%-7.41M | ---- | 122.81%9.34M | ---- | 224.87%4.19M | ---- | -59.63%-3.36M | ---- | 15.47%-2.1M |
| Accounts payable increase (decrease) | ---- | 628.76%35.93M | ---- | 173.16%4.93M | ---- | 60.03%-6.74M | ---- | -281.07%-16.86M | ---- | 151.67%9.31M |
| prepayments (increase)decrease | ---- | -326.73%-2.75M | ---- | 435.73%1.21M | ---- | 89.65%-361K | ---- | 33.63%-3.49M | ---- | -155.00%-5.25M |
| Special items for working capital changes | ---- | 198.90%544K | ---- | 131.22%182K | ---- | -3.55%-583K | ---- | -298.94%-563K | ---- | 122.02%283K |
| Cash from business operations | ---- | 37.94%55.18M | ---- | 129.49%40M | ---- | 431.76%17.43M | ---- | -92.93%3.28M | ---- | 28.31%46.34M |
| Other taxs | ---- | 176.78%248K | ---- | -179.75%-323K | ---- | 109.21%405K | ---- | -496.57%-4.4M | ---- | 312.45%1.11M |
| Interest received - operating | ---- | -27.78%117K | ---- | 752.63%162K | ---- | 11.76%19K | ---- | 0.00%17K | ---- | -19.05%17K |
| Special items of business | -127.67%-6.02M | ---- | 409.37%21.76M | ---- | -526.04%-7.03M | ---- | 145.72%1.65M | ---- | -124.86%-3.61M | ---- |
| Net cash from operations | -127.67%-6.02M | 39.41%55.54M | 409.37%21.76M | 123.14%39.84M | -526.04%-7.03M | 1,718.77%17.86M | 145.72%1.65M | -102.32%-1.1M | -124.86%-3.61M | 33.28%47.46M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | 6,712.50%545K | ---- | -95.85%8K | ---- | 565.52%193K | ---- | -94.46%29K | ---- | -17.90%523K |
| Purchase of fixed assets | ---- | -17.28%-25.26M | ---- | -102.26%-21.54M | ---- | 70.63%-10.65M | ---- | 10.98%-36.26M | ---- | 10.26%-40.74M |
| Purchase of intangible assets | ---- | -165.91%-9.52M | ---- | -17,795.00%-3.58M | ---- | ---20K | ---- | ---- | ---- | ---294K |
| Other items in the investment business | -31.25%-7.74M | ---- | -469.32%-5.9M | ---- | 175.15%1.6M | ---- | 95.26%-2.13M | ---- | -162.03%-44.81M | ---- |
| Net cash from investment operations | -31.25%-7.74M | -36.33%-34.24M | -469.32%-5.9M | -139.69%-25.11M | 175.15%1.6M | 71.09%-10.48M | 95.26%-2.13M | 10.55%-36.24M | -162.03%-44.81M | 9.50%-40.51M |
| Net cash before financing | -186.76%-13.76M | 44.67%21.31M | 391.76%15.86M | 99.63%14.73M | -1,047.05%-5.44M | 119.76%7.38M | 99.02%-474K | -637.01%-37.34M | -1,779.66%-48.42M | 176.01%6.95M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 11.98%263.92M | ---- | 36.76%235.68M | ---- | -6.80%172.33M | ---- | 12.33%184.91M | ---- | -1.32%164.61M |
| Refund | ---- | -8.37%-264.81M | ---- | -34.90%-244.35M | ---- | -22.28%-181.13M | ---- | 10.99%-148.13M | ---- | -12.07%-166.42M |
| Issuing shares | ---- | ---- | ---- | --18.6M | ---- | ---- | ---- | --35.61M | ---- | ---- |
| Interest paid - financing | ---- | 7.20%-12.02M | ---- | -45.70%-12.96M | ---- | -31.11%-8.89M | ---- | 1.18%-6.78M | ---- | 4.60%-6.86M |
| Pledged bank deposit (increase) decrease | ---- | 77.49%-1.11M | ---- | ---4.91M | ---- | ---- | ---- | ---1.95M | ---- | ---- |
| Other items of the financing business | 86.20%-2.12M | ---- | -168.96%-15.33M | ---- | 263.48%22.22M | ---- | -125.29%-13.59M | ---- | 9,948.79%53.76M | ---- |
| Net cash from financing operations | 86.20%-2.12M | -46.47%-17.66M | -168.96%-15.33M | 44.94%-12.06M | 263.48%22.22M | -136.81%-21.9M | -125.29%-13.59M | 637.21%59.49M | 9,948.79%53.76M | -232.15%-11.07M |
| Effect of rate | 251.46%1.87M | -218.92%-354K | -31.76%-1.23M | 81.56%-111K | 58.79%-935K | -2,508.00%-602K | -276.58%-2.27M | -92.77%25K | 146.64%1.29M | 414.55%346K |
| Net Cash | -3,056.61%-15.88M | 36.56%3.65M | -96.80%537K | 118.40%2.67M | 219.32%16.79M | -165.54%-14.52M | -363.40%-14.07M | 637.56%22.15M | 361.69%5.34M | -436.59%-4.12M |
| Begining period cash | 13.69%27.36M | 11.91%24.07M | 11.91%24.07M | -41.28%21.51M | -41.28%21.51M | 153.46%36.63M | 153.46%36.63M | -20.71%14.45M | -20.71%14.45M | -4.60%18.23M |
| Cash at the end | -42.87%13.35M | 13.69%27.36M | -37.43%23.37M | 11.91%24.07M | 84.10%37.36M | -41.28%21.51M | -3.72%20.29M | 153.46%36.63M | 26.16%21.08M | -20.71%14.45M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --21.08M | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --21.08M | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Liang Xuelian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Liang Xuelian (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.